NET Patient Rob Hammond speaks at the Senate Inquiry hearing in Tasmania

NET Patient and passionate advocate and fundraiser Rob Hammond shared his story and the plight of NET Patients Australia wide at the Senate Inquiry into “Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer” in Hobart on February 20.

Rob spoke about the challenges around accessing optimal care and the inequities that NET patients face living in Tasmania, including referral pathways, HCP education and low awareness of the disease amongst the general public and healthcare professional community. He touched on the challenges he has faced during this advocacy work and thanked Senator Wendy Askew for the opportunity to speak and feel heard. Thank you Rob for sharing not only your own story, but one that will resonate with so many Tasmanian and NET patients and indeed patients Australia wide.

Listen to Robs full speech here.

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

ANZSNM 56th Annual Conference – Canberra (ACT), Australia

Nurses Workshop, Sunday, 17 May 2026

NECA Joins Boehringer Ingelheim Panel Discussion on Clinical Trials and Patient Access

Healing NETS Summit

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.